Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$405M |
| 2 |
Gilead Sciences
GILD
|
+$314M |
| 3 |
Union Pacific
UNP
|
+$229M |
| 4 |
Intel
INTC
|
+$224M |
| 5 |
Meta Platforms (Facebook)
META
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$342M |
| 2 |
SWY
SAFEWAY INC
SWY
|
+$210M |
| 3 |
TSMC
TSM
|
+$174M |
| 4 |
GSK
GSK
|
+$156M |
| 5 |
Johnson & Johnson
JNJ
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.05% |
| 2 | Technology | 11.94% |
| 3 | Consumer Discretionary | 11.2% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Staples | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Telus
TU
$16.2B
| $104M | 0.22% |
6,268,600
+376,200
| +6% | +$6.51M |
|
77
Aptiv
APTV
$12.2B
| $103M | 0.22% |
1,297,400
+1,078,500
| +493% | +$81M |
|
|
SPLS
78
DELISTED
Staples Inc
SPLS
| $102M | 0.22% |
+6,277,679
| New | +$105M |
|
79
Clorox
CLX
$11.8B
| $101M | 0.21% |
913,500
-308,500
| -25% | -$33.5M |
|
|
MJN
80
DELISTED
Mead Johnson Nutrition Company
MJN
| $99M | 0.21% |
985,000
+432,800
| +78% | +$43.7M |
|
81
National Grid
NGG
$81.6B
| $98.7M | 0.21% |
1,583,512
+17,828
| +1% | +$1.17M |
|
82
O'Reilly Automotive
ORLY
$75.1B
| $98M | 0.21% |
6,796,410
+1,123,500
| +20% | +$15.1M |
|
83
Edwards Lifesciences
EW
$47.8B
| $95.2M | 0.2% |
4,010,400
+1,103,400
| +38% | +$24.8M |
|
84
Bausch Health
BHC
$1.67B
| $94.5M | 0.2% |
475,837
+436,848
| +1,120% | +$77.5M |
|
85
Baidu
BIDU
$35.8B
| $94.2M | 0.2% |
451,900
+170,400
| +61% | +$36.5M |
|
|
ECHO
86
EchoStar
ECHO
$25.1B
| $93.1M | 0.2% |
2,222,409
+10,859
| +0.5% | +$462K |
|
87
American Express
AXP
$229B
| $92.7M | 0.2% |
+1,186,600
| New | +$98.6M |
|
88
PPG Industries
PPG
$26.4B
| $92.2M | 0.2% |
+818,000
| New | +$93.7M |
|
89
Macerich
MAC
$7.41B
| $92.2M | 0.2% |
1,092,964
+421,464
| +63% | +$36.9M |
|
90
Usana Health Sciences
USNA
$412M
| $91.3M | 0.19% |
1,643,166
+47,400
| +3% | +$2.43M |
|
91
Pfizer
PFE
$141B
| $91.2M | 0.19% |
+2,764,053
| New | +$87.9M |
|
92
DuPont de Nemours
DD
$18.9B
| $90.4M | 0.19% |
+744,272
| New | +$88.3M |
|
|
NTT
93
DELISTED
Nippon Telegraph & Telephone
NTT
| $89M | 0.19% |
2,886,320
-512,380
| -15% | -$15.2M |
|
|
94
Johnson & Johnson
JNJ
$641B
| $87.2M | 0.19% |
867,200
-1,469,500
| -63% | -$149M |
|
95
Entergy
ETR
$53.1B
| $85.7M | 0.18% |
2,212,200
+277,400
| +14% | +$11.4M |
|
96
Ultrapar
UGP
$6.71B
| $85.5M | 0.18% |
8,467,400
-351,600
| -4% | -$3.43M |
|
97
Procter & Gamble
PG
$346B
| $85.5M | 0.18% |
1,043,128
-1,692,771
| -62% | -$146M |
|
|
SEE
98
DELISTED
Sealed Air
SEE
| $85.1M | 0.18% |
1,868,100
+1,719,500
| +1,157% | +$76.3M |
|
|
PCYC
99
DELISTED
PHARMACYCLICS INC
PCYC
| $84.9M | 0.18% |
331,700
+223,700
| +207% | +$43.2M |
|
100
Zoetis
ZTS
$32.2B
| $84.4M | 0.18% |
1,822,794
+1,172,294
| +180% | +$52.9M |
|
Similar funds
Renaissance Technologies's Q1 2015 Portfolio in Review
As of Q1 2015, Renaissance Technologies held 3,575 positions worth $47B, up 13% from $41.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
Renaissance Technologies deployed $4.23B of net new capital in Q1 2015, opening 633 new positions and adding to 1,637 existing holdings. Its largest new stake was Amazon: 23,057,100 shares worth $429M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was McDonald's, an estimated $342M trimmed.
- Renaissance Technologies's largest Q1 2015 buy was Amazon: 23,057,100 shares worth $429M.
- Renaissance Technologies added most to Gilead Sciences in Q1 2015, an estimated $314M increase.
- Renaissance Technologies's biggest Q1 2015 reduction was McDonald's, cutting an estimated $342M.
- Renaissance Technologies fully exited SAFEWAY INC in Q1 2015, selling an estimated $210M.
- Renaissance Technologies's ten largest holdings make up 9.9% of its $47B portfolio in Q1 2015.
- Renaissance Technologies opened 633 new positions and closed 438 in Q1 2015.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $47B.
Based on Renaissance Technologies's 13F filing for Q1 2015, filed 13 May 2015.